Eli Lilly Launches Online Platform for Obesity Drugs, Connecting Patients with Telehealth Services

Indianapolis, IN – Pharmaceutical giant Eli Lilly has launched a new website called LillyDirect, aimed at connecting patients with obesity drugs such as Zepbound and Mounjaro. The platform, which allows patients to order drugs directly from the company, also offers remote access to doctors through telehealth services. Eli Lilly CEO David Ricks explained that the website was created to address the difficulties faced by patients seeking obesity treatments. The company’s move follows similar initiatives by WW International (formerly Weight Watchers) and Ro. However, concerns have been expressed regarding the prescription of drugs without an in-person consultation.

The American College of Physicians (ACP) expressed unease over websites that enable patients to directly order prescription medications from drugmakers. While the ACP acknowledges the importance of removing barriers to care, it emphasizes the need for an established patient-physician relationship or consultation with a physician who has such a relationship. Critics have raised concerns about the potential drawbacks of “direct-to-consumer advertising,” noting the importance of a balanced and neutral approach to healthcare.

Eli Lilly has emphasized that its drugs are intended for obesity treatment and should not be used for cosmetic weight loss. The company aims to address the concerns of medical professionals regarding obesity drugs like Ozempic, which have been associated with potential dangers. As the popularity of weight loss drugs increases, telehealth-connected websites like LillyDirect provide patients with simplified options for accessing care and medication.

In conclusion, Eli Lilly has launched a new telehealth-connected website, LillyDirect, to facilitate access to obesity drugs. The platform offers a direct ordering system and remote access to doctors. While there are concerns about prescribing medications without an in-person consultation, the company aims to address the difficulties faced by patients seeking obesity treatments. Other companies, like WW International and Ro, have also initiated similar online platforms. The American College of Physicians warns of the potential confusion and misinformation that may arise from direct-to-consumer medication ordering. Eli Lilly emphasizes that its drugs should be used for medical purposes and not for cosmetic weight loss.